Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis

Peritonitis remains a primary challenge for the long-term success of peritoneal dialysis (PD) technique and one of the main reasons for catheter removal. Prevention and treatment of catheter-related infections are major concerns to avoid peritonitis. The use of taurolidine catheter-locking solution...

Full description

Bibliographic Details
Main Authors: Marta Alvarez Nadal, R. Haridian Sosa Barrios, Víctor Burguera Vion, Cristina Campillo Trapero, Milagros Fernández Lucas, Maite E. Rivera Gorrín
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Kidney Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059520301357
id doaj-c19e2853e891473a8f4452bf404f97f4
record_format Article
spelling doaj-c19e2853e891473a8f4452bf404f97f42020-11-25T03:38:19ZengElsevierKidney Medicine2590-05952020-09-0125650651Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis PeritonitisMarta Alvarez Nadal0R. Haridian Sosa Barrios1Víctor Burguera Vion2Cristina Campillo Trapero3Milagros Fernández Lucas4Maite E. Rivera Gorrín5Servicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, SpainServicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, Spain; Grupo de Nefrología Diagnóstica e Intervencionista _(GNDI) de la Sociedad Española de Nefrología, Madrid, Spain; Address for Correspondence: R. Haridian Sosa Barrios, MD, MSc, Ctra Colmenar Viejo km 9.1, 28034 Madrid, Spain.Servicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, Spain; Grupo de Nefrología Diagnóstica e Intervencionista _(GNDI) de la Sociedad Española de Nefrología, Madrid, SpainServicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, SpainServicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, Spain; Grupo de Nefrología Diagnóstica e Intervencionista _(GNDI) de la Sociedad Española de Nefrología, Madrid, Spain; Universidad de Alcalá, UAH, Madrid, Spain; Instituto Ramón y Cajal de Investigaciones Sanitarias (IryCis), Madrid, Spain; Red de Investigación Renal (RedinREn), Madrid, SpainServicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, Spain; Grupo de Nefrología Diagnóstica e Intervencionista _(GNDI) de la Sociedad Española de Nefrología, Madrid, Spain; Universidad de Alcalá, UAH, Madrid, Spain; Instituto Ramón y Cajal de Investigaciones Sanitarias (IryCis), Madrid, Spain; Red de Investigación Renal (RedinREn), Madrid, SpainPeritonitis remains a primary challenge for the long-term success of peritoneal dialysis (PD) technique and one of the main reasons for catheter removal. Prevention and treatment of catheter-related infections are major concerns to avoid peritonitis. The use of taurolidine catheter-locking solution to avoid the development of a biofilm in the catheter’s lumen has obtained good results in hemodialysis catheters for reducing infection rates, although there is scarce literature available regarding its utility in PD. We describe the case of a woman in her 60s who developed relapsing peritonitis due to Pseudomonas aeruginosa, with no possibility of removing peritoneal dialysis catheter because she was not a suitable candidate for hemodialysis. After the fourth peritonitis episode caused by Pseudomonas species, the use of taurolidine catheter-locking solution was initiated. She received a total of 9 doses, with a favorable microbiological and clinical outcome and no further relapses more than 10 months after taurolidine PD catheter lock treatment was started. We report the successful elimination of an aggressive bacteria after taurolidine PD catheter lock use, with no relevant adverse events.http://www.sciencedirect.com/science/article/pii/S2590059520301357TaurolidinePseudomonas peritonitisperitoneal dialysisbiofilmcatheter lock
collection DOAJ
language English
format Article
sources DOAJ
author Marta Alvarez Nadal
R. Haridian Sosa Barrios
Víctor Burguera Vion
Cristina Campillo Trapero
Milagros Fernández Lucas
Maite E. Rivera Gorrín
spellingShingle Marta Alvarez Nadal
R. Haridian Sosa Barrios
Víctor Burguera Vion
Cristina Campillo Trapero
Milagros Fernández Lucas
Maite E. Rivera Gorrín
Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
Kidney Medicine
Taurolidine
Pseudomonas peritonitis
peritoneal dialysis
biofilm
catheter lock
author_facet Marta Alvarez Nadal
R. Haridian Sosa Barrios
Víctor Burguera Vion
Cristina Campillo Trapero
Milagros Fernández Lucas
Maite E. Rivera Gorrín
author_sort Marta Alvarez Nadal
title Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
title_short Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
title_full Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
title_fullStr Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
title_full_unstemmed Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
title_sort taurolidine peritoneal dialysis catheter lock to treat relapsing peritoneal dialysis peritonitis
publisher Elsevier
series Kidney Medicine
issn 2590-0595
publishDate 2020-09-01
description Peritonitis remains a primary challenge for the long-term success of peritoneal dialysis (PD) technique and one of the main reasons for catheter removal. Prevention and treatment of catheter-related infections are major concerns to avoid peritonitis. The use of taurolidine catheter-locking solution to avoid the development of a biofilm in the catheter’s lumen has obtained good results in hemodialysis catheters for reducing infection rates, although there is scarce literature available regarding its utility in PD. We describe the case of a woman in her 60s who developed relapsing peritonitis due to Pseudomonas aeruginosa, with no possibility of removing peritoneal dialysis catheter because she was not a suitable candidate for hemodialysis. After the fourth peritonitis episode caused by Pseudomonas species, the use of taurolidine catheter-locking solution was initiated. She received a total of 9 doses, with a favorable microbiological and clinical outcome and no further relapses more than 10 months after taurolidine PD catheter lock treatment was started. We report the successful elimination of an aggressive bacteria after taurolidine PD catheter lock use, with no relevant adverse events.
topic Taurolidine
Pseudomonas peritonitis
peritoneal dialysis
biofilm
catheter lock
url http://www.sciencedirect.com/science/article/pii/S2590059520301357
work_keys_str_mv AT martaalvareznadal taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis
AT rharidiansosabarrios taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis
AT victorburgueravion taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis
AT cristinacampillotrapero taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis
AT milagrosfernandezlucas taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis
AT maiteeriveragorrin taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis
_version_ 1724542871456972800